GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China Health Group Ltd (HKSE:00673) » Definitions » Cash Flow from Financing

China Health Group (HKSE:00673) Cash Flow from Financing : HK$11.63 Mil (TTM As of Sep. 2023)


View and export this data going back to 1996. Start your Free Trial

What is China Health Group Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Sep. 2023, China Health Group paid HK$0.00 Mil more to buy back shares than it received from issuing new shares. It received HK$0.00 Mil from issuing more debt. It paid HK$0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received HK$0.00 Mil from paying cash dividends to shareholders. It received HK$0.00 Mil on other financial activities. In all, China Health Group spent HK$0.00 Mil on financial activities for the six months ended in Sep. 2023.


China Health Group Cash Flow from Financing Historical Data

The historical data trend for China Health Group's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Health Group Cash Flow from Financing Chart

China Health Group Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.96 4.98 2.56 12.81 27.66

China Health Group Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.53 13.34 23.10 4.56 7.07

China Health Group Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

China Health Group's Cash from Financing for the fiscal year that ended in Mar. 2023 is calculated as:

China Health Group's Cash from Financing for the quarter that ended in Sep. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$11.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Health Group  (HKSE:00673) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

China Health Group's issuance of stock for the six months ended in Sep. 2023 was HK$0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

China Health Group's repurchase of stock for the six months ended in Sep. 2023 was HK$0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

China Health Group's net issuance of debt for the six months ended in Sep. 2023 was HK$0.00 Mil. China Health Group received HK$0.00 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

China Health Group's net issuance of preferred for the six months ended in Sep. 2023 was HK$0.00 Mil. China Health Group paid HK$0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

China Health Group's cash flow for dividends for the six months ended in Sep. 2023 was HK$0.00 Mil. China Health Group received HK$0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

China Health Group's other financing for the six months ended in Sep. 2023 was HK$0.00 Mil. China Health Group received HK$0.00 Mil on other financial activities.


China Health Group Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of China Health Group's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


China Health Group (HKSE:00673) Business Description

Traded in Other Exchanges
N/A
Address
141 Des Voeux Road, Unit 801, 8th Floor, China Insurance Group Building, Central, Hong Kong, HKG
China Health Group Ltd is an investment holding company. It is principally engaged in the distribution and service of medical equipment and consumables, provision of hospital operation and management service, and business factoring. It operates in the business in three segments Distribution and service in medical equipment and consumables; Hospital operation and management services and Business factoring service. It derives a majority of revenue from the Distribution and service in the medical equipment and consumables segment. Geographically the group's locations are located in the PRC.

China Health Group (HKSE:00673) Headlines

No Headlines